Literature DB >> 2506136

Beta interferon inhibits Toxoplasma gondii growth in human monocyte-derived macrophages.

J L Schmitz1, J M Carlin, E C Borden, G I Byrne.   

Abstract

Gamma interferon (IFN-gamma) previously has been shown to block the replication of Toxoplasma gondii in fibroblasts by the induction of indoleamine 2,3-dioxygenase (IDO) activity. IFN-beta also is known to induce IDO activity in monocyte-derived macrophages, but its ability to block the growth of T. gondii has not been demonstrated. We found not only that the combination of IFN-beta and lipopolysaccharide induced greater IDO activity in monocyte-derived macrophages than did IFN-beta alone but that this combination also was effective in inhibiting the growth of T. gondii. In addition, the inhibition was reversed by the addition of exogenous tryptophan, thus demonstrating that a mechanism by which IFN-beta inhibited T. gondii replication was by the induction of IDO.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2506136      PMCID: PMC260802          DOI: 10.1128/iai.57.10.3254-3256.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  Biologic-response-modifier-induced indoleamine 2,3-dioxygenase activity in human peripheral blood mononuclear cell cultures.

Authors:  J M Carlin; E C Borden; P M Sondel; G I Byrne
Journal:  J Immunol       Date:  1987-10-01       Impact factor: 5.422

2.  Interferon-induced indoleamine 2,3-dioxygenase activity in human mononuclear phagocytes.

Authors:  J M Carlin; E C Borden; P M Sondel; G I Byrne
Journal:  J Leukoc Biol       Date:  1989-01       Impact factor: 4.962

3.  Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells.

Authors:  G I Byrne; L K Lehmann; G J Landry
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

4.  Rapid separation of tryptophan, kynurenines, and indoles using reversed-phase high-performance liquid chromatography.

Authors:  S Yong; S Lau
Journal:  J Chromatogr       Date:  1979-07-13

5.  Gamma-interferon is the factor in lymphokine that activates human macrophages to inhibit intracellular Chlamydia psittaci replication.

Authors:  C D Rothermel; B Y Rubin; H W Murray
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

6.  Interferon-induced indoleamine 2,3-dioxygenase activity inhibits Chlamydia psittaci replication in human macrophages.

Authors:  J M Carlin; E C Borden; G I Byrne
Journal:  J Interferon Res       Date:  1989-06

7.  The actions of interferon and antiinflammatory agents of induction of indoleamine 2,3-dioxygenase in human peripheral blood monocytes.

Authors:  Y Ozaki; M P Edelstein; D S Duch
Journal:  Biochem Biophys Res Commun       Date:  1987-05-14       Impact factor: 3.575

8.  Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan.

Authors:  E R Pfefferkorn
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

9.  Lymphokine-mediated inhibition of Chlamydia replication in mouse fibroblasts is neutralized by anti-gamma interferon immunoglobulin.

Authors:  G I Byrne; D A Krueger
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

10.  Role of tryptophan degradation in respiratory burst-independent antimicrobial activity of gamma interferon-stimulated human macrophages.

Authors:  H W Murray; A Szuro-Sudol; D Wellner; M J Oca; A M Granger; D M Libby; C D Rothermel; B Y Rubin
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

View more
  28 in total

1.  Replication of Toxoplasma gondii, but not Trypanosoma cruzi, is regulated in human fibroblasts activated with gamma interferon: requirement of a functional JAK/STAT pathway.

Authors:  I P Cerávolo; A C Chaves; C A Bonjardim; D Sibley; A J Romanha; R T Gazzinelli
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

Review 2.  Toxoplasma Effectors Targeting Host Signaling and Transcription.

Authors:  Mohamed-Ali Hakimi; Philipp Olias; L David Sibley
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

3.  Mechanisms of interferon-induced inhibition of Toxoplasma gondii replication in human retinal pigment epithelial cells.

Authors:  C N Nagineni; K Pardhasaradhi; M C Martins; B Detrick; J J Hooks
Journal:  Infect Immun       Date:  1996-10       Impact factor: 3.441

4.  Production of interferons in human placental trophoblast subpopulations and their possible roles in pregnancy.

Authors:  G Aboagye-Mathiesen; F D Tóth; M Zdravkovic; P Ebbesen
Journal:  Clin Diagn Lab Immunol       Date:  1994-11

5.  Expression of indoleamine 2,3-dioxygenase, tryptophan degradation, and kynurenine formation during in vivo infection with Toxoplasma gondii: induction by endogenous gamma interferon and requirement of interferon regulatory factor 1.

Authors:  Neide M Silva; Cibele V Rodrigues; Marcelo M Santoro; Luiz F L Reis; Jacqueline I Alvarez-Leite; Ricardo T Gazzinelli
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

6.  Elevated interleukin-27 levels in human neonatal macrophages regulate indoleamine dioxygenase in a STAT-1 and STAT-3-dependent manner.

Authors:  Joo-Yong Jung; Madeline Gleave Parson; Jennifer D Kraft; Logan Lyda; Brianna Kobe; Celestia Davis; Jembber Robinson; Maria Marjorette O Peña; Cory M Robinson
Journal:  Immunology       Date:  2016-09       Impact factor: 7.397

7.  Recombinant murine beta interferon enhances resistance of mice to systemic Mycobacterium avium infection.

Authors:  M Denis
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

8.  Inhibition of Legionella pneumophila growth by gamma interferon in permissive A/J mouse macrophages: role of reactive oxygen species, nitric oxide, tryptophan, and iron(III).

Authors:  S J Gebran; Y Yamamoto; C Newton; T W Klein; H Friedman
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

9.  Establishment of an antitoxoplasma state by stable expression of mouse indoleamine 2,3-dioxygenase.

Authors:  A Habara-Ohkubo; T Shirahata; O Takikawa; R Yoshida
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

10.  Synergistic transcriptional activation of indoleamine dioxygenase by IFN-gamma and tumor necrosis factor-alpha.

Authors:  Cory M Robinson; Kari Ann Shirey; Joseph M Carlin
Journal:  J Interferon Cytokine Res       Date:  2003-08       Impact factor: 2.607

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.